In this piece for TIME, Mandy Oaklander provides a comprehensive review of the current status of and potential future directions for the depression treatment industry. The article explores the pluses and minuses of various new treatments for depression, including the use of ketamine, and also describes non-drug approaches including exercise, CBT, and behavioral-activation therapy.
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.